Works matching IS 00071048 AND DT 2019 AND VI 187 AND IP 3

Results: 29
    1
    2
    3
    4
    5

    Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014‐04 (Etoile du Nord) trial.

    Published in:
    British Journal of Haematology, 2019, v. 187, n. 3, p. 319, doi. 10.1111/bjh.16059
    By:
    • Boyle, Eileen M.;
    • Leleu, Xavier;
    • Petillon, Marie‐Odile;
    • Karlin, Lionel;
    • Doyen, Chantal;
    • Demarquette, Hélène;
    • Royer, Bruno;
    • Macro, Margaret;
    • Moreau, Philippe;
    • Fostier, Karel;
    • Marie‐Lorraine, Chretien;
    • Zarnitsky, Charles;
    • Perrot, Aurore;
    • Herbaux, Charles;
    • Poulain, Stephanie;
    • Manier, Salomon;
    • Beauvais, David;
    • Walker, Brian A.;
    • Wardell, Christopher P.;
    • Vincent, Laure
    Publication type:
    Article
    6

    Negative CD19 expression is associated with inferior relapse‐free survival in children with RUNX1‐RUNX1T1–positive acute myeloid leukaemia: results from the Japanese Paediatric Leukaemia/Lymphoma Study Group AML‐05 study.

    Published in:
    British Journal of Haematology, 2019, v. 187, n. 3, p. 372, doi. 10.1111/bjh.16080
    By:
    • Sakamoto, Kenichi;
    • Shiba, Norio;
    • Deguchi, Takao;
    • Kiyokawa, Nobutaka;
    • Hashii, Yoshiko;
    • Moriya‐Saito, Akiko;
    • Tomizawa, Daisuke;
    • Taga, Takashi;
    • Adachi, Soichi;
    • Horibe, Keizo;
    • Imamura, Toshihiko
    Publication type:
    Article
    7
    8

    Point of care testing in general haematology.

    Published in:
    British Journal of Haematology, 2019, v. 187, n. 3, p. 296, doi. 10.1111/bjh.16208
    By:
    • Mooney, Ciaran;
    • Byrne, Mary;
    • Kapuya, Patience;
    • Pentony, Lorna;
    • De la Salle, Barbara;
    • Cambridge, Tony;
    • Foley, David
    Publication type:
    Article
    9
    10

    Infectious complications after post‐transplantation cyclophosphamide and anti‐thymocyte globulin‐based haploidentical stem cell transplantation.

    Published in:
    British Journal of Haematology, 2019, v. 187, n. 3, p. e64, doi. 10.1111/bjh.16189
    By:
    • Mohty, Razan;
    • Brissot, Eolia;
    • Battipaglia, Giorgia;
    • Ruggeri, Annalisa;
    • Dulery, Rémy;
    • Bonnin, Agnès;
    • Médiavilla, Clémence;
    • Sestili, Simona;
    • Belhocine, Ramdane;
    • Vekhoff, Anne;
    • Ledraa, Tounes;
    • Lapusan, Camelia Simona;
    • Adaeva, Rosa;
    • Isnard, Françoise;
    • Legrand, Olivier;
    • Mohty, Mohamad;
    • Malard, Florent
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17

    Association of gene mutations with time‐to‐first treatment in 384 treatment‐naive chronic lymphocytic leukaemia patients.

    Published in:
    British Journal of Haematology, 2019, v. 187, n. 3, p. 307, doi. 10.1111/bjh.16042
    By:
    • Hu, Boyu;
    • Patel, Keyur P.;
    • Chen, Hsiang‐Chun;
    • Wang, Xuemei;
    • Luthra, Rajyalakshmi;
    • Routbort, Mark J.;
    • Kanagal‐Shamanna, Rashmi;
    • Medeiros, L. Jeffrey;
    • Yin, C. Cameron;
    • Zuo, Zhuang;
    • Ok, Chi Y.;
    • Loghavi, Sanam;
    • Tang, Guilin;
    • Tambaro, Francesco P.;
    • Thompson, Philip;
    • Burger, Jan;
    • Jain, Nitin;
    • Ferrajoli, Alessandra;
    • Bose, Prithviraj;
    • Estrov, Zeev
    Publication type:
    Article
    18

    Issue Information.

    Published in:
    British Journal of Haematology, 2019, v. 187, n. 3, p. 265, doi. 10.1111/bjh.15484
    Publication type:
    Article
    19
    20

    How we manage Bing–Neel syndrome.

    Published in:
    British Journal of Haematology, 2019, v. 187, n. 3, p. 277, doi. 10.1111/bjh.16167
    By:
    • Castillo, Jorge J.;
    • Treon, Steven P.
    Publication type:
    Article
    21
    22
    23
    24

    Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era.

    Published in:
    British Journal of Haematology, 2019, v. 187, n. 3, p. 364, doi. 10.1111/bjh.16090
    By:
    • Prusila, Roosa E. I.;
    • Sorigue, Marc;
    • Jauhiainen, Jyrki;
    • Mercadal, Santiago;
    • Postila, Aleksi;
    • Salmi, Petteri;
    • Tanhua, Taru;
    • Tikkanen, Susanna;
    • Kakko, Sakari;
    • Kuitunen, Hanne;
    • Pollari, Marjukka;
    • Nystrand, Ilja;
    • Kuusisto, Milla E. L.;
    • Vasala, Kaija;
    • Jantunen, Esa;
    • Korkeila, Eija;
    • Karihtala, Peeter;
    • Sancho, Juan‐Manuel;
    • Turpeenniemi‐Hujanen, Taina;
    • Kuittinen, Outi
    Publication type:
    Article
    25

    CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib.

    Published in:
    British Journal of Haematology, 2019, v. 187, n. 3, p. 356, doi. 10.1111/bjh.16088
    By:
    • Castillo, Jorge J.;
    • Xu, Lian;
    • Gustine, Joshua N.;
    • Keezer, Andrew;
    • Meid, Kirsten;
    • Dubeau, Toni E.;
    • Liu, Xia;
    • Demos, Maria G.;
    • Kofides, Amanda;
    • Tsakmaklis, Nicholas;
    • Chen, Jiaji G.;
    • Munshi, Manit;
    • Guerrera, Maria L.;
    • Chan, Gloria G.;
    • Patterson, Christopher J.;
    • Yang, Guang;
    • Hunter, Zachary R.;
    • Treon, Steven P.
    Publication type:
    Article
    26

    Rituximab‐PECC induction followed by <sup>90</sup>Y‐ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study.

    Published in:
    British Journal of Haematology, 2019, v. 187, n. 3, p. 347, doi. 10.1111/bjh.16087
    By:
    • Lugtenburg, Pieternella J.;
    • Zijlstra, Josee M.;
    • Doorduijn, Jeanette K.;
    • Böhmer, Lara H.;
    • Hoogendoorn, Mels;
    • Berenschot, Henriette W.;
    • Beeker, Aart;
    • van der Burg‐de Graauw, Nicole C.;
    • Schouten, Harry C.;
    • Bilgin, Yavuz M.;
    • Kersten, Marie‐Jose;
    • Koene, Harry R.;
    • Herbers, Alexandra H. E.;
    • de Jong, Daphne;
    • Hijmering, Nathalie;
    • Lam, King H.;
    • Chiţu, Dana;
    • Brouwer, Rolf E.;
    • van Imhoff, Gustaaf W.
    Publication type:
    Article
    27
    28

    Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome.

    Published in:
    British Journal of Haematology, 2019, v. 187, n. 3, p. 337, doi. 10.1111/bjh.16083
    By:
    • Berger, Marc G.;
    • Pereira, Bruno;
    • Rousselot, Philippe;
    • Cony‐Makhoul, Pascale;
    • Gardembas, Martine;
    • Legros, Laurence;
    • Escoffre‐Barbe, Martine;
    • Nicolini, Franck‐Emmanuel;
    • Saugues, Sandrine;
    • Lambert, Céline;
    • Réa, Delphine;
    • Guerci‐Bresler, Agnès;
    • Giraudier, Stéphane;
    • Guilhot, Joëlle;
    • Saussele, Susanne;
    • Mahon, François‐Xavier
    Publication type:
    Article
    29